Covista Inc. (CVSA) Stock
Key stats
- Market cap
- $3.98B
- Price / Earnings ratio
- 15.1x
- EPS (TTM)
- $7.44
- Volume
- Loading
- 52-week high
- $142.13
- 52-week low
- $86.97
Source: third-party data provider, as of November 13, 2026
Compare with CVSA
Recent news

Here's Why Covista (CVSA) is a Strong Growth Stock
Here's Why Covista (CVSA) is a Strong Growth Stock
CVSA

Covista (CVSA) Beats Q1 Earnings and Revenue Estimates
Covista (CVSA) Beats Q1 Earnings and Revenue Estimates
CVSA

Covista Reports First Quarter Fiscal Year 2027 Results; Raises Fiscal Year 2027 Revenue and Adjusted EPS Guidance
Covista Reports First Quarter Fiscal Year 2027 Results; Raises Fiscal Year 2027 Revenue and Adjusted EPS Guidance
CVSA

Covista Recognized by TIME and Newsweek for Growth, Workplace Culture and Sustainability
Covista Recognized by TIME and Newsweek for Growth, Workplace Culture and Sustainability
CVSA
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 44.50
- MACD 12/26/9
- -2.98
- EMA 9 of MACD
- -1.84
- MACD histogram
- -1.14
- SMA 50
- $125.18
- Price below SMA 50
- EMA 50
- $124.71
- Price below EMA 50
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2026Earnings
No data available
Source: third-party data provider
Latest news

Here's Why Covista (CVSA) is a Strong Growth Stock
Here's Why Covista (CVSA) is a Strong Growth Stock
CVSA

Covista (CVSA) Beats Q1 Earnings and Revenue Estimates
Covista (CVSA) Beats Q1 Earnings and Revenue Estimates
CVSA

Covista Reports First Quarter Fiscal Year 2027 Results; Raises Fiscal Year 2027 Revenue and Adjusted EPS Guidance
Covista Reports First Quarter Fiscal Year 2027 Results; Raises Fiscal Year 2027 Revenue and Adjusted EPS Guidance
CVSA

Covista Recognized by TIME and Newsweek for Growth, Workplace Culture and Sustainability
Covista Recognized by TIME and Newsweek for Growth, Workplace Culture and Sustainability
CVSA

Chamberlain University Opens First Utah Campus and 26th Location Nationwide, Expanding Nursing Education in the State with the Fewest Nurses per Capita
Chamberlain University Opens First Utah Campus and 26th Location Nationwide, Expanding Nursing Education in the State with the Fewest Nurses per Capita
CVSA

Why Covista (CVSA) is a Top Momentum Stock for the Long-Term
Why Covista (CVSA) is a Top Momentum Stock for the Long-Term
CVSA

Why Covista (CVSA) is a Top Growth Stock for the Long-Term
Why Covista (CVSA) is a Top Growth Stock for the Long-Term
CVSA

Why Covista (CVSA) is a Top Value Stock for the Long-Term
Why Covista (CVSA) is a Top Value Stock for the Long-Term
CVSA

Students at Covista Medical Schools Match or Exceed U.S. MD Peers on USMLE Step 1 First-Time Pass Rates Across MCAT Ranges
Students at Covista Medical Schools Match or Exceed U.S. MD Peers on USMLE Step 1 First-Time Pass Rates Across MCAT Ranges
CVSA

The DAISY Foundation® Names Walden University an Extraordinary Educational Partner
The DAISY Foundation® Names Walden University an Extraordinary Educational Partner
CVSA
News tone: automated (AI) classification of the article's content, not a price prediction.
About Covista Inc.
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Stephen W. Beard J.D. | CEO & Chairman | 1971 |
| Mr. Robert J. Phelan CPA | Senior VP & CFO | 1966 |
| Mr. Douglas G. Beck J.D. | Senior VP of Institutional Support Services, General Counsel & Corporate Secretary | 1967 |
| Mr. Michael Betz | Chief Growth & Innovation Officer and President of Walden University | 1974 |
| Mr. Scott Day Liles | Chief Strategy & Performance Officer and President of Medical and Veterinary | 1966 |
| Mr. Manjunath Gangadharan | VP & Chief Accounting Officer | 1983 |
| Mr. Jeremy Cohen | Vice President of Investor Relations | — |
| Ms. Sara Hill | Senior VP & Chief Human Resources Officer | 1969 |
| Ms. Megan Noel | Senior VP & Chief Corporate Affairs Officer | 1985 |
| Ms. Amelia Manning | President of Chamberlain University | 1974 |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 44.50
- MACD 12/26/9
- -2.98
- EMA 9 of MACD
- -1.84
- MACD histogram
- -1.14
- SMA 50
- $125.18
- Price below SMA 50
- EMA 50
- $124.71
- Price below EMA 50
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $140.00
- Average
- $142.50
- High
- $145.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.6 | +15.5 | -1.2 | +3.5 | +2.1 | -2.6 | +3.8 | -8.5 | +0.8 | -3.6 |



